Skip to Main Content

Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation (FORWARD)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by:

Fundacion GESICA

ClinicalTrials.gov Identifier:

NCT00597220

First received: January 8, 2008

Last updated: June 21, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2011
Estimated Primary Completion Date:	July 2011 (Final data collection date for primary outcome measure)

No publications provided by Fundacion GESICA

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J Am Coll Cardiol. 2013 Jan 29;61(4):463-8. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.

Macchia A, Varini S, Grancelli H, Nul D, Laffaye N, Ferrante D, Tognoni G, Doval HC; FORomegaARD investigators. The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation. Am Heart J. 2009 Mar;157(3):423-7. Epub 2009 Jan 8.